CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,813,971
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,813,971. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 45 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-28 | Walker Karin L Chief Accounting Officer | Exercise or conversion | +15,000 | 25,000 | ||
| 2026-07-28 | Walker Karin L Chief Accounting Officer | Returned to the company | −15,000 | $8.56 | $128K | 10,000 |
| 2026-07-28 | Walker Karin L Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −15,000 | 0 | ||
| 2026-03-03 | Walker Karin L Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-07-28 | Walker Karin L Chief Accounting Officer | Grant or award | +25,000 | 25,000 | ||
| 2025-03-05 | Walker Karin L Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-02-27 | Walker Karin L Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2024-01-24 | Walker Karin L Chief Accounting Officer | Exercise or conversion 10b5-1 | +5,000 | $13.53 | $68K | 5,000 |
| 2024-01-24 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −5,000 | $34.00 | $170K | 0 |
| 2024-01-24 | Walker Karin L Chief Accounting Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 15,000 | ||
| 2023-12-20 | Walker Karin L Chief Accounting Officer | Exercise or conversion 10b5-1 | +5,000 | $13.53 | $68K | 5,000 |
| 2023-12-20 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −1,678 | $36.68 | $62K | 3,322 |
| 2023-12-20 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −3,322 | $37.45 | $124K | 0 |
| 2023-12-20 | Walker Karin L Chief Accounting Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 20,000 | ||
| 2023-11-30 | Walker Karin L Chief Accounting Officer | Exercise or conversion 10b5-1 | +5,000 | $13.53 | $68K | 5,000 |
| 2023-11-30 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −5,000 | $34.00 | $170K | 0 |
| 2023-11-30 | Walker Karin L Chief Accounting Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 25,000 | ||
| 2023-10-25 | Walker Karin L Chief Accounting Officer | Exercise or conversion 10b5-1 | +5,000 | $13.53 | $68K | 5,000 |
| 2023-10-25 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −1,789 | $40.27 | $72K | 3,211 |
| 2023-10-25 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −2,917 | $41.38 | $121K | 294 |
Page 1 of 8 · 148 trades